摘要
目的 为临床多囊卵巢综合征不孕不育患者合理用药提供参考.方法 采用回顾性调查方法,统计2018年多囊卵巢综合征不孕不育患者门诊处方的药品品种、数量、用药频度(DDDs)及销售金额等进行分析.结果 该院多囊卵巢综合征不孕不育患者使用的药品以口服药为主,占比53.26%,其次为注射剂;在用药金额上,注射剂所占金额比例最高,占65.59%,其中,促排卵药及性激素类药物是其主要用药,金额占比90.47%.药品的用药金额和用药频度呈现出明显的不同步性.结论 该院多囊卵巢综合征不孕不育门诊处方用药比较合理,但一些促排卵药物价格较高,在一定程度上加重了患者负担.
Objective To provide a reference for rational drug use in clinical infertility patients with polycystic ovary syndrome(PCOS).Methods By retrospective survey method,to analyze the types,quantities,DDDs and consumption sum of drugs prescribed by our hospital for infertility patients with polycystic ovary syndrome in 2018.Results Oral medicine was major type of medicines in infertility patients with polycystic ovary syndrome in our hospital,accounting for 53.26%,followed by injection.In total consumption sum,the sum of injection accounted for highest proportion,accounting for 65.59%,of which ovulation stimulants drugs and sex hormone class medicine drugs were main drug,accounting for 90.47%of the consumption sum.The consumption sum and DDDs showed obvious asynchronism.Conclusion The outpatient prescription drug in infertility patients with PCOS in our hospital is reasonable,but expensive ovulation stimulants increase the burden of patients to some extent.
作者
黄敏
尹小丽
HUANG Min;YIN Xiao-li(Reproductive Hospital of Shandong University,Jinan 250021,China)
出处
《中国处方药》
2020年第8期58-60,共3页
Journal of China Prescription Drug
